{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:01:59Z","timestamp":1790974919999,"version":"4.1.0"},"reference-count":74,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T00:00:00Z","timestamp":1432771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0128398","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T18:06:22Z","timestamp":1432836382000},"page":"e0128398","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1\u03b1 Protein and Mitochondrial Content"],"prefix":"10.1371","volume":"10","author":[{"given":"Craig A.","family":"Goodman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derk","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Zacharewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Lee-Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod J.","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn K.","family":"McConell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrd1112","article-title":"Lovastatin and beyond: the history of the HMG-CoA Reductase inhibitors","volume":"2","author":"JA Tobert","year":"2003","journal-title":"Nat Rev Drug Discovery"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/hrt.2008.151506","article-title":"Statins: established indications and controversial subgroups","volume":"94","author":"JW Jukema","year":"2008","journal-title":"Heart"},{"key":"ref3","article-title":"Application of New Cholesterol Guidelines to a Population-Based Sample","author":"MJ Pencina","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ecl.2008.11.002","article-title":"Managing Statin Myopathy","volume":"38","author":"CV Venero","year":"2009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MOL.0b013e32825a6773","article-title":"The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis","volume":"18","author":"CR Harper","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3949\/ccjm.78a.10073","article-title":"Statin myopathy: A common dilemma not reflected in clinical trials","volume":"78","author":"G Fernandez","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients\u2014The PRIMO Study","volume":"19","author":"E Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/JES.0b013e31826c169e","article-title":"Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes","volume":"40","author":"BA Parker","year":"2012","journal-title":"Exerc Sport Sci Rev"},{"key":"ref9","article-title":"Statins and physical activity in older men: The osteoporotic fractures in men study","author":"DH Lee","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism","volume":"8","author":"BA Golomb","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2217\/14622416.9.8.1133","article-title":"Molecular basis for statin-induced muscle toxicity: implications and possibilities","volume":"9","author":"C Buettner","year":"2008","journal-title":"Pharmacogenomics"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/mus.21817","article-title":"Statin-associated myopathy and its exacerbation with exercise","volume":"42","author":"BM Meador","year":"2010","journal-title":"Muscle & Nerve"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.bbamcr.2011.07.019","article-title":"Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt","volume":"1813","author":"PJ Mullen","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Molecular Cell Research"},{"key":"ref14","first-page":"3940","article-title":"The muscle-specific ubiquitin ligase atrogin-1\/MAFbx mediates statin-induced muscle toxicity","volume":"117","author":"JI Hanai","year":"2007","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1096\/fj.08-128843","article-title":"Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect","volume":"23","author":"P Cao","year":"2009","journal-title":"FASEB J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1113\/jphysiol.2008.164699","article-title":"Blunted Akt\/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy","volume":"587","author":"JE Mallinson","year":"2009","journal-title":"J Physiol (London)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e72858","DOI":"10.1371\/journal.pone.0072858","article-title":"Effects of Lipid-Lowering Drugs on Irisin in Human Subjects <italic>In Vivo<\/italic> and in Human Skeletal Muscle Cells <italic>Ex Vivo<\/italic>","volume":"8","author":"I Gouni-Berthold","year":"2013","journal-title":"PLoS ONE"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1113\/jphysiol.2012.238022","article-title":"Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents","volume":"590","author":"JE Mallinson","year":"2012","journal-title":"The Journal of Physiology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.atherosclerosis.2004.06.014","article-title":"Statin myotoxicity is associated with changes in the cardiopulmonary function","volume":"177","author":"PS Phillips","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin-Associated Myopathy with Normal Creatine Kinase Levels","volume":"137","author":"PS Phillips","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref21","first-page":"85","article-title":"Mitochondrial alterations in muscle biopsies of patients on statin therapy","volume":"36","author":"S Gambelli","year":"2004","journal-title":"J Submicrosc Cytol Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2125.1996.04178.x","article-title":"Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate\/pyruvate ratio","volume":"42","author":"G De Pinieux","year":"1996","journal-title":"Brit J Clin Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/eurheartj\/ehr224","article-title":"Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a &apos;mitohormesis&apos; mechanism involving reactive oxygen species and PGC-1","volume":"33","author":"J Bouitbir","year":"2011","journal-title":"European Heart Journal"},{"key":"ref24","first-page":"878","article-title":"Utility of Abnormal 3-Methylglutaconic Aciduria (3MGA) in Diagnosing Statin-Associated Myopathy","volume":"22","author":"PS Phillips","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/01926230590908213","article-title":"Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity","volume":"33","author":"FR Westwood","year":"2005","journal-title":"Toxicol Pathol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.lfs.2008.01.021","article-title":"Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathy","volume":"82","author":"Dorajoo Rso","year":"2008","journal-title":"Life Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.bbrc.2005.10.108","article-title":"Simvastatin induces impairment in skeletal muscle while heart is protected","volume":"338","author":"P Sirvent","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.taap.2007.06.003","article-title":"Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration","volume":"223","author":"S Nadanaciva","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00018-006-6235-z","article-title":"Toxicity of statins on rat skeletal muscle mitochondria","volume":"63","author":"P Kaufmann","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"H Paiva","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.clpt.6100124","article-title":"Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin","volume":"81","author":"BA Schick","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.04.009","article-title":"Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: Implications for statin-induced rhabdomyolysis","volume":"711","author":"RA Vaughan","year":"2013","journal-title":"European Journal of Pharmacology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1152\/physrev.00025.2007","article-title":"Transcriptional Paradigms in Mammalian Mitochondrial Biogenesis and Function","volume":"88","author":"RC Scarpulla","year":"2008","journal-title":"Physiol Rev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0607795103","article-title":"PGC-1\u03b1 protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription","volume":"103","author":"M Sandri","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"19460","DOI":"10.1074\/jbc.M110.113092","article-title":"Peroxisome Proliferator-activated Receptor \u03b3 Coactivator 1\u03b1 or 1\u03b2 Overexpression Inhibits Muscle Protein Degradation, Induction of Ubiquitin Ligases, and Disuse Atrophy","volume":"285","author":"JJ Brault","year":"2010","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"20186","DOI":"10.1074\/jbc.M803020200","article-title":"Reactive Nitrogen Species Is Required for the Activation of the AMP-activated Protein Kinase by Statin in Vivo","volume":"283","author":"HC Choi","year":"2008","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/ATVBAHA.108.172452","article-title":"AMP-Activated Protein Kinase Promotes the Differentiation of Endothelial Progenitor Cells","volume":"28","author":"X Li","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1161\/CIRCULATIONAHA.106.630194","article-title":"Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo","volume":"114","author":"W Sun","year":"2006","journal-title":"Circulation"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/cvr\/cvt070","article-title":"HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome","volume":"99","author":"N Hermida","year":"2013","journal-title":"Cardiovasc Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1161\/ATVBAHA.107.154492","article-title":"Statin Treatment and 3&apos; Polyadenylation of eNOS mRNA","volume":"27","author":"I Kosmidou","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"H2785","DOI":"10.1152\/ajpheart.00149.2008","article-title":"Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS\/NO upregulation but not via PDGF-BB expression","volume":"294","author":"T Fujii","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/01.ATV.0000251615.61858.33","article-title":"Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt\/NF-kappaB pathway","volume":"27","author":"S Nakata","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1097\/HJH.0b013e32833e0924","article-title":"Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats","volume":"28","author":"D Ito","year":"2010","journal-title":"J Hypertens"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.cellsig.2011.07.013","article-title":"Recent Progress towards Understanding the Molecular Mechanisms that Regulate Skeletal Muscle Mass","volume":"23","author":"CA Goodman","year":"2011","journal-title":"Cell Signal"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1172\/JCI30654","article-title":"NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS","volume":"117","author":"N Suzuki","year":"2007","journal-title":"J Clin Invest"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2010.03.022","article-title":"Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis","volume":"294","author":"N Suzuki","year":"2010","journal-title":"J Neurol Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200241050-00003","article-title":"Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors","volume":"41","author":"D Williams","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"ref48","article-title":"Rosuvastatin: Characterization of Induced Myopathy in the Rat","author":"FR Westwood","year":"2008","journal-title":"Toxicol Pathol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0022-3565(25)24759-0","article-title":"HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies","volume":"257","author":"PF Smith","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2003.08.013","article-title":"Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats","volume":"194","author":"WH Schaefer","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref51","first-page":"393","article-title":"Maternal creatine supplementation from mid-pregnancy protects the newborn spiny mouse diaphragm from intrapartum hypoxia-induced damage","volume":"68","author":"DJ Cannata","year":"2010","journal-title":"Pediatr Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1096\/fj.05-5249fje","article-title":"Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1","volume":"20","author":"B Leger","year":"2006","journal-title":"FASEB J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1152\/japplphysiol.00549.2006","article-title":"Effect of nitric oxide synthase inhibition on mitochondrial biogenesis in rat skeletal muscle","volume":"102","author":"GD Wadley","year":"2007","journal-title":"J Appl Physiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"23925","DOI":"10.1074\/jbc.M109.021048","article-title":"Skeletal Muscle AMP-activated Protein Kinase Is Essential for the Metabolic Response to Exercise in Vivo","volume":"284","author":"RS Lee-Young","year":"2009","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1210\/me.2011-1124","article-title":"Myostatin Induces Degradation of Sarcomeric Proteins through a Smad3 Signaling Mechanism During Skeletal Muscle Wasting","volume":"25","author":"S Lokireddy","year":"2011","journal-title":"Mol Endocrinol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"C1248","DOI":"10.1152\/ajpcell.00104.2009","article-title":"Smad2 and 3 transcription factors control muscle mass in adulthood","volume":"296","author":"R Sartori","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1055\/s-0028-1082051","article-title":"Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway","volume":"40","author":"H Kaji","year":"2008","journal-title":"Horm Metab Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e3959","DOI":"10.1371\/journal.pone.0003959","article-title":"Essential Role of TGF-\u03b2\/Smad Pathway on Statin Dependent Vascular Smooth Muscle Cell Regulation","volume":"3","author":"J Rodr\u00edguez-Vita","year":"2008","journal-title":"PLoS ONE"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1113\/jphysiol.2012.230185","article-title":"Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects","volume":"590","author":"S Larsen","year":"2012","journal-title":"The Journal of Physiology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jns.2012.12.023","article-title":"Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy","volume":"325","author":"HAJ Stringer","year":"2013","journal-title":"J Neurol Sci"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4093\/dmj.2013.37.5.301","article-title":"Regulation of Muscle Pyruvate Dehydrogenase Complex in Insulin Resistance: Effects of Exercise and Dichloroacetate","volume":"37","author":"D Constantin-Teodosiu","year":"2013","journal-title":"Diabetes Metab J"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy","volume":"117","author":"M Sandri","year":"2004","journal-title":"Cell"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription Factors","volume":"14","author":"TN Stitt","year":"2004","journal-title":"Mol Cell"},{"key":"ref64","first-page":"n\/a","article-title":"Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: the roles of long chain fatty acids","author":"M Hafizi Abu Bakar","year":"2014","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0006-2952(91)90654-N","article-title":"Effect of simvastatin (MK-733) on plasma triacylglycerol levels in rats","volume":"41","author":"A Sato","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1194\/jlr.M600301-JLR200","article-title":"Effects of lipoprotein lipase and statins on cholesterol uptake into heart and skeletal muscle","volume":"48","author":"M Yokoyama","year":"2007","journal-title":"J Lipid Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2012.06.019","article-title":"AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesity","volume":"366","author":"HM O\u2019Neill","year":"2013","journal-title":"Molecular and Cellular Endocrinology"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbrc.2012.08.138","article-title":"AMP-activated protein kinase stimulates myostatin expression in C2C12 cells","volume":"427","author":"AK Das","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.metabol.2012.03.010","article-title":"Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase","volume":"61","author":"M Ohira","year":"2012","journal-title":"Metabolism"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00228-002-0556-0","article-title":"Beyond lipid-lowering: effects of statins on endothelial nitric oxide","volume":"58","author":"U Laufs","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors","volume":"97","author":"U Laufs","year":"1998","journal-title":"Circulation"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","article-title":"Rho GTPases, Statins, and Nitric Oxide","volume":"97","author":"Y Rikitake","year":"2005","journal-title":"Circ Res"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","article-title":"Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase","volume":"273","author":"U Laufs","year":"1998","journal-title":"J Biol Chem"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/jpet.107.136028","article-title":"Simvastatin Inhibits Central Sympathetic Outflow in Heart Failure by a Nitric-Oxide Synthase Mechanism","volume":"326","author":"L Gao","year":"2008","journal-title":"J Pharmacol Exp Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0128398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:07:14Z","timestamp":1748405234000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0128398"}},"subtitle":[],"editor":[{"given":"Ashok","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,28]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0128398","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,28]]}}}